Back

It is possible to avoid an ICD implantation with empagliflozine?

30 April 2017 (15:50 - 15:56)
Organised by:
Congress Presentation Part of: Clinical Case Corner 3 - Metabolic issues in heart failure: don't forget periphery! Chronic heart failure HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mr Jose Morgado

University Hospital of Virgen Macarena, Seville (Spain)

7 More presentations in this session

Presentation thumbnail
Acute right heart failure in thyroid storm: warranting early thyroidectomy
Doctor O. Abou Hassan (Beirut, LB)
Presentation thumbnail
Simultaneous anterior and inferior ST segment elevation during hypoglycemia: myocardial infarction or Tako-tsubo cardiomyopathy?
Doctor S. Ferretto (San Dona di Piave, IT)
Presentation thumbnail
Metabolic cardiomyopathy with heart failure: a late, reversible complication of bariatric surgery.
Assistant Professor G. Pela (Parma, IT)
Presentation thumbnail
An unusual cause of dilated cardiomyopathy
Doctor A. Mendez Fernandez (Barcelona, ES)
Presentation thumbnail
Diabetes, deafness and hypertrophic cardiomyopathy: is it just a coincidence?
Doctor V. Rial Baston (Glasgow, GB)
Slides

Access the full session

Session thumbnail
Clinical Case Corner 3 - Metabolic issues in heart failure: don't forget periphery!

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 15:50 CET
You may be interested in
thumbnail
Congress Presentation
Effect of dapagliflozin on ventricular arrhythmic events in heart failure patients with implantable defibrillator.
12 May 2024
thumbnail
Congress Presentation
Extravascular-ICD implantation procedure: step-by-step
25 August 2023
thumbnail
Congress Presentation
Exploring the psychological and practical needs of informal caregivers of patients with Implantable Cardioverter Defibrillators
14 June 2025
thumbnail
Congress Presentation
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources